Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

NCT05819398 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

209

Enrollment

INDUSTRY

Sponsor class

Conditions

Hidradenitis Suppurativa

Interventions

DRUG: Spesolimab i.v.
DRUG: Spesolimab s.c.
DRUG: Placebo matching Spesolimab i.v.
DRUG: Placebo matching Spesolimab s.c.

Sponsor

Boehringer Ingelheim